A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
Clinical trial NCT00000772 · COMPLETED
Trial details
- NCT number
- NCT00000772
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.